SEC Filing Summary: Amerigon Incorporated (10-Q)
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Amerigon Incorporated for the period ended March 31, 2007. Amerigon designs and markets proprietary thermoelectric components, primarily the ClimateControl Seat (CCS), which provides heating and cooling for automotive seats. The company has shipped approximately 2.84 million CCS units since 2000. The company also holds an 85% interest in BSST LLC, a subsidiary focused on developing advanced thermoelectric devices.
Key Financial Metrics
| Metric | Q1 2007 | Q1 2006 |
|---|---|---|
| Product Revenues | $16,273,000 | $10,441,000 |
| Gross Margin | $5,214,000 (32.0%) | $3,308,000 (31.7%) |
| Operating Income | $1,918,000 | $1,078,000 |
| Net Income | $1,294,000 | $768,000 |
| Diluted EPS | $0.06 | $0.03 |
| Cash & Equivalents | $2,911,000 | $1,956,000 (End of Period) |
| Short-term Investments | $15,525,000 | $12,076,000 (Dec 31, 2006) |
| Working Capital | $26,365,000 | $23,765,000 (Dec 31, 2006) |
| Accumulated Deficit | $(48,150,000) | $(49,444,000) (Dec 31, 2006) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 56% year-over-year, driven by new model introductions (e.g., Cadillac EXT, Land Rover Range Rover) and higher volumes on redesigned models. Unit shipments rose to 240,000 from 144,000.
- Profitability: Net income increased 68% to $1.294 million. Operating income grew 78% to $1.918 million.
- Expense Increases: Net R&D expenses rose 80% to $1.143 million due to advanced TED program activities. SG&A expenses increased 35% to $2.153 million, largely due to higher stock option compensation and management incentive plan costs.
- Inventory Reduction: Inventory decreased 56% to $1.904 million as management reduced stock levels, aided by higher-than-planned revenue volume.
- Geographic Mix: North American revenue share decreased from 77% to 63%, while Asian revenue share increased from 23% to 33%.
Guidance, Outlook, and Risks
- Outlook: Management expects net R&D expenses to increase for the remainder of 2007 as development of advanced TED technology continues. Cash used in investing activities is expected to include approximately $1.5 million in Q2 and Q3 2007 for leasehold improvements at the Irwindale, California engineering center.
- Liquidity: The company maintains a $10 million revolving line of credit with no borrowings outstanding as of March 31, 2007. Management believes current cash, short-term investments, and future revenues are sufficient to meet operating needs for the foreseeable future.
- Risks:
- Single Product Reliance: The company relies almost exclusively on the CCS product; failure to commercialize new products could materially harm the business.
- Supply Chain: Production is outsourced to Ferrotec Corporation in China. Disruptions or delays could impact delivery and incur penalties.
- Customer Concentration: Sales depend on acceptance by major OEMs (Ford, GM, Toyota, Nissan, Hyundai). Customers can unilaterally cancel contracts or demand price reductions.
- Intellectual Property: The company faces risks regarding patent protection and potential litigation from competitors.
- Accounting Changes: The company adopted FASB Interpretation 48 (FIN 48) on January 1, 2007, regarding uncertainty in income taxes. The adoption did not have a material impact on financial statements.
Investor Verification Checklist
- Verify the sustainability of the 56% revenue growth given the mix shift toward lower-content CCS systems.
- Confirm the status of new model introductions and the timeline for replacing models that ended production (e.g., Cadillac Escalade ESV Platinum, Lincoln LS).
- Assess the impact of the 80% increase in R&D expenses on future profitability and the timeline for commercializing advanced TED products.
- Review the concentration of accounts payable with Ferrotec Corporation ($2.159 million) and the risks associated with outsourced manufacturing in China.
- Monitor the company's ability to maintain its $10 million revolving credit facility and manage liquidity as R&D spending increases.